MTI, FDA Revisit Onyx Aneurysm Trial Protocol: Enrollment Struggles Cited
This article was originally published in The Gray Sheet
Executive Summary
Micro Therapeutics, Inc. is in discussions with FDA over revising its Onyx LES liquid embolic system brain aneurysm trial to better demonstrate efficacy in treating wide-necked aneurysms